Skip to content

Cocktail analgesics during spinal surgery

Local infiltration with cocktail analgesics( Ropivacaine/Methylprednisolone/Ketoprofen)during spinal surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs041190102
Enrollment
46
Registered
2019-12-24
Start date
2020-01-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

scoliosis

Interventions

Group A: control group A total 40ml of saline is injected into the paraspinal muscle at the time of closure. Group B: cocktali group A total 40ml of cocktail analgesics, which 0.75% ropivacaine 20 m

Sponsors

Yoshida Go
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with scoliosis surgery and age of 12 years to 25 years old 2. Informed consent obtained for patients

Exclusion criteria

Exclusion criteria: 1. Patients with a history of local anesthetic allergy (such as xylocaine) 2. Patients with severe preoperative paralysis (manual muscle strength test 3 or less) 3. Patients with peptic ulcer 4. Patients with severe blood abnormalities 5. Patients with aspirin asthma 6. Patients with severe liver dysfunction 7. Patients with severe renal dysfunction 8. Patients with severe cardiac dysfunction 9. Patients with difficult pain assessment (such as intellectual disabilities) 10. Women who are pregnant or may be pregnant 11. Breastfeeding woman 12. Patinets who are judged to be inappropriate for research participation by the principal investigator

Design outcomes

Primary

MeasureTime frame
Pain score of postoperative pain (Numerical rating scale [NRS] 0 to 10 points)

Secondary

MeasureTime frame
1. Rescue usage (total epidural usage, transvenous analgesia usage and rescue frequency, total acetaminophen usage frequency and usage) 2. Adverse event

Contacts

Public ContactKoichiro Ide

Hamamatsu University Hospital

1de.5one60@gmail.com+81-53-435-2299

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026